Transactivation of miR-34a by p53 Broadly Influences Gene Expression and Promotes Apoptosis

Cited by (1,000)

Items 901–1,000 of 1,000

1. Ursodeoxycholic acid: Effects on hepatic unfolded protein response, apoptosis and oxidative stress in morbidly obese patients
   Michaela Mueller, Rui Eduardo Castro, Anders Thorell, Hanns–Ulrich Marschall, Nicole Auer, Merima Herac, Cecília M. P. Rodrigues, Michael A Trauner · 2017 · Liver International
2. MicroRNAs: Important Regulators of Induced Pluripotent Stem Cell Generation and Differentiation
   Zhaolin Zeng, Xiaolong Lin, Li-Lan Tan, Yami Liu, Kai Qu, Zuo Wang · 2017 · Stem Cell Reviews and Reports
3. Expression of mitochondrial membrane–linked SAB determines severity of sex-dependent acute liver injury
   Sanda Win, Robert Win Maw Min, Christopher Q. Chen, Jun Zhang, Yibu Chen, Meng Li, Ayako Suzuki, Manal F. Abdelmalek, Ying Wang, Mariam Aghajan et al. · 2019 · Journal of Clinical Investigation
4. Capsaicin Targets tNOX (ENOX2) to Inhibit G1 Cyclin/CDK Complex, as Assessed by the Cellular Thermal Shift Assay (CETSA)
   Atikul Islam, Ally J. Su, Zih-Ming Zeng, Pin Ju Chueh, Ming-Hung Lin · 2019 · Cells
5. The role of microRNA-34 family in Alzheimer’s disease: A potential molecular link between neurodegeneration and metabolic disorders
   Maryam Bazrgar, Pariya Khodabakhsh, Mercedes Prudencio, Fatemeh Mohagheghi, Abolhassan Ahmadiani · 2021 · Pharmacological Research
6. The role of extracellular vesicles in cellular senescence
   Valentín Estévez‐Souto, Sabela Da Silva‐Álvarez, Manuel Collado · 2022 · FEBS Journal
7. Dynamic Nature of Noncoding RNA Regulation of Adaptive Immune Response
   Graziella Curtale, Franca Citarella · 2013 · International Journal of Molecular Sciences
8. Roles and Mechanisms of MicroRNAs in Pancreatic Cancer
   Lidong Zhang, Md Saha Jamaluddin, Sarah M. Weakley, Qizhi Cathy Yao, Changyi Chen · 2011 · World Journal of Surgery
9. miR-98 regulates cisplatin-induced A549 cell death by inhibiting TP53 pathway
   Shuai Zhang, Chao Zhang, Youjie Li, Pingyu Wang, Zhen Yue, Shuyang Xie · 2011 · Biomedicine & Pharmacotherapy
10. p53, SKP2, and DKK3 as MYCN Target Genes and Their Potential Therapeutic Significance
    Lindi Chen, Deborah A. Tweddle · 2012 · Frontiers in Oncology
11. TBHP-induced oxidative stress alters microRNAs expression in mouse testis
    Nayeralsadat Fatemi, Mohammad Hossein Sanati, Mehdi Shamsara, Fariborz Moayer, Mansour Jamali Zavarehei, Alireza Pouya, Forough-Azam Sayahpour, Hoda Ayat, Hamid Gourabi · 2014 · Journal of Assisted Reproduction and Genetics
12. microRNAs and death receptors
    Sun-Mi Park, Marcus E. Peter · 2008 · Cytokine & Growth Factor Reviews
13. Role of the micro RNA , miR‐206, and its target PIK 3C2α in endothelial progenitor cell function – potential link with coronary artery disease
    Yong Tang, Yachen Zhang, Yu Chen, Xiang Yin, Yuquan Xie · 2015 · FEBS Journal
14. Genetic Networks Lead and Follow Tumor Development: MicroRNA Regulation of Cell Cycle and Apoptosis in the p53 Pathways
    Kurataka Otsuka, Takahiro Ochiya · 2014 · BioMed Research International
15. miR-34a Expression, Cell Cycle Arrest and Cell Death of Malignant Mesothelioma Cells upon Treatment with Radiation, Docetaxel or Combination Treatment
    Taha Ghawanmeh, Ulf Thunberg, Juan Castro, Fiona Murray, Nongnit Laytragoon‐Lewin · 2011 · Oncology
16. MicroRNAs in Hepatobiliary and Pancreatic Cancers
    Yoshimasa Saito, Hidekazu Suzuki, Misa Matsuura, Ayami Sato, Yusuke Kasai, Kana Yamada, Hidetsugu Saito, Toshifumi Hibi∥ · 2011 · Frontiers in Genetics
17. Regression of A549 lung cancer tumors by anti-miR-150 vector
    Changjun Lv · 2011 · Oncology Reports
18. p53 inhibits mRNA 3′ processing through its interaction with the CstF/BARD1 complex
    Fathima I. Nazeer, Emral Devany, S Mohammed, Danae Fonseca, B Akukwe, C Taveras, Frida E. Kleiman · 2011 · Oncogene
19. MicroRNAs that respond to histone deacetylase inhibitor SAHA and p53 in HCT116 human colon carcinoma cells
    An · 2009 · International Journal of Oncology
20. Noncoding RNAs in Regulation of Cancer Metabolic Reprogramming
    Dongdong Yang, Linchong Sun, Zhaoyong Li, Ping Gao · 2016 · Advances in experimental medicine and biology
21. MicroRNA-34 dysregulation in gastric cancer and gastric cancer stem cell
    Narjes Jafari, Saeid Abediankenari · 2017 · Tumor Biology
22. Protective effects of crocin and zinc sulfate on hepatic ischemia-reperfusion injury in rats: a comparative experimental model study
    Seyyed Ali Mard, Ghaidafeh Akbari, Mahin Dianat, Esrafil Mansouri · 2017 · Biomedicine & Pharmacotherapy
23. p53 Regulates the Expression of LRP1 and Apoptosis through a Stress Intensity-Dependent MicroRNA Feedback Loop
    Patrick L. Leslie, Derek A. Franklin, Yong U. Liu, Yanping Zhang · 2018 · Cell Reports
24. MicroRNA-34a regulates high glucose-induced apoptosis in H9c2 cardiomyocytes
    Fang Zhao, Bo Li, Yin-zhi Wei, Bin Zhou, Han Wang, Ming Chen, Xuedong Gan, Zhaohui Wang, Shixi Xiong · 2013 · Journal of Huazhong University of Science and Technology [Medical Sciences]
25. The E2F1-miRNA Cancer Progression Network
    Susanne Knoll, Stephan Emmrich, Brigitte M. Pützer · 2012 · Advances in experimental medicine and biology
26. The Interactions of microRNA and Epigenetic Modifications in Prostate Cancer
    Prashant Kumar Singh, Moray J. Campbell · 2013 · Cancers
27. The tumor suppressor axis p53/miR-34a regulates Axl expression in B-cell chronic lymphocytic leukemia: implications for therapy in p53-defective CLL patients
    Justin C. Boysen, Sutapa Sinha, Tammy L. Price-Troska, S L Warner, David J. Bearss, David S. Viswanatha, Tait D. Shanafelt, Neil E. Kay, Asish K. Ghosh · 2013 · Leukemia
28. miR-34a Inhibits Proliferation and Invasion of Bladder Cancer Cells by Targeting Orphan Nuclear Receptor HNF4G
    Huaibin Sun, Jun Tian, Wanhua Xian, Tingting Xie, Xiangdong Yang · 2015 · Disease Markers
29. Principles of microRNA involvement in human cancers
    Hui Yvonne Ling, Wei Zhang, George A. Călin · 2011 · 癌症：英文版
30. Species‐specific micro RNA regulation influences phenotypic variability
    Eyal Mor, Noam Shomron · 2013 · BioEssays
31. M i R ‐34a deficiency accelerates medulloblastoma formation in vivo
    Theresa Thor, Annette Künkele, Kristian W. Pajtler, Annika K. Wefers, Harald Stephan, Pieter Mestdagh, Lukas Carl Heukamp, Wolfgang Hartmann, Jo Vandesompele, Natalie Sadowski et al. · 2014 · International Journal of Cancer
32. Noncoding RNAs in Cancer Development
    Chao‐Po Lin, Lin He · 2016 · Annual Review of Cancer Biology
33. Urinary sediment miRNAs reflect tubulointerstitial damage and therapeutic response in IgA nephropathy
    Shuang Liang, Guangyan Cai, Zhi-Yu Duan, Shuwen Liu, Jie Wu, Yang Lv, Kai Hou, Zuoxiang Li, Xue-Guang Zhang, Xiangmei Chen · 2017 · BMC Nephrology
34. MicroRNA–target cross-talks: Key players in glioblastoma multiforme
    Eman Ali Toraih, Nagwa M. Aly, Hoda Y. Abdallah, Saeed Awad M. Alqahtani, Aly A. M. Shaalan, Mohammad Hosny Hussein, Manal Said Fawzy · 2017 · Tumor Biology
35. Non-coding RNAs, guardians of the p53 galaxy
    Song Chen, Rick Francis Thorne, Xu Dong Zhang, Mian Wu, Lianxin Liu · 2020 · Seminars in Cancer Biology
36. Circulating exosomal microRNAs as emerging non‐invasive clinical biomarkers in heart failure: Mega bio‐roles of a nano bio‐particle
    Runfa Zhou, Leiyan Wang, Gang Zhao, Dan Chen, Xiaoning Song, Amir Abbas Momtazi‐Borojeni, Haitao Yuan · 2020 · IUBMB Life
37. An Insight on the Role of Altered Function and Expression of Exosomes and MicroRNAs in Female Reproductive Diseases
    Maryam Javadi, Jafar Soleimani Rad, Mohammad Sadegh Gholami Farashah, Leila Roshangar · 2021 · Reproductive Sciences
38. The role of microRNAs on doxorubicin drug resistance in breast cancer
    Khadijeh Jamialahmadi, Fatemeh Zahedipour, Gholamreza Karimi · 2021 · Journal of Pharmacy and Pharmacology
39. Genomic analysis of microRNA time-course expression in liver of mice treated with genotoxic carcinogen N-ethyl-N-nitrosourea
    Zhiguang Li, William S. Branham, Stacey L. Dial, Yexun Wang, Lei Guo, Leming M. Shi, Tao Chen · 2010 · BMC Genomics
40. MicroRNAs in Pancreatic Cancer: Involvement in Carcinogenesis and Potential Use for Diagnosis and Prognosis
    Tereza Hálková, Romana Čuperková, Marek Minárik, Lucie Benešová · 2015 · Gastroenterology Research and Practice
41. MicroRNA-34 Family, Mechanisms of Action in Cancer: A Review
    Hamidreza Maroof, Ali Salajegheh, Robert Anthony Smith, Alfred King-yin Lam · 2014 · Current Cancer Drug Targets
42. MicroRNAs are significantly influenced by p53 and radiation in HCT116 human colon carcinoma cells
    An · 2009 · International Journal of Oncology
43. MicroRNAs as Potential Biomarkers of Smoking-Related Diseases
    Anisha Banerjee, Karsta Luettich · 2012 · Biomarkers in Medicine
44. MicroRNAs as New Players for Diagnosis, Prognosis, and Therapeutic Targets in Breast Cancer
    Enders K. O. Ng, C. Wong, Edmond S.K. Ma, Ava Kwong · 2009 · Journal of Oncology
45. In vitro combinatory effects of the Alternaria mycotoxins alternariol and altertoxin II and potentially involved miRNAs
    Katharina Vejdovszky, Matej Sack, Katharina Jarolim, Georg Aichinger, Mark Manuel Somoza, Doris Marko · 2016 · Toxicology Letters
46. Expression profile of MicroRNA: An Emerging Hallmark of Cancer
    Uzma Zaheer, Muhammed Faheem, Ishtiaq Qadri, Nargis Begum, Hadi Mohamad Yassine, Asmaa A. Al Thani, Shilu Mathew · 2019 · Current Pharmaceutical Design
47. ATM /miR‐34a‐5p axis regulates a p21‐dependent senescence‐apoptosis switch in non‐small cell lung cancer: a Boolean model of G1/S checkpoint regulation
    Shantanu Gupta, Daner A. Silveira, José C. M. Mombach · 2019 · FEBS Letters
48. miRNAs as Regulators of Antidiabetic Effects of Fucoidans
    Chao Zhao, Shanshan Lai, Desheng Wu, Dan Liu, Xiaobo Zou, Amin Ismail, Hesham Rushdey El-Seedi, Randolph Arroo, Jianbo Xiao · 2019 · eFood
49. The Mir181ab1 cluster promotes KRAS-driven oncogenesis and progression in lung and pancreas
    Karmele Valencia, Oihane Erice, Kaja Kostyrko, Simone Hausmann, Elizabeth Guruceaga, Anuradha Tathireddy, Natasha Mahealani Flores, Leanne C. Sayles, Alex Gia Lee, Rita Fragoso et al. · 2019 · Journal of Clinical Investigation
50. Circulating Small Noncoding RNAs Have Specific Expression Patterns in Plasma and Extracellular Vesicles in Myelodysplastic Syndromes and Are Predictive of Patient Outcome
    Andrea Hruštincová, Zdeněk Krejčík, Dávid Kundrát, Katarína Szikszai, Monika Beličková, Pavla Pecherková, Jǐŕı Kléma, Jitka Veselá, Monika Kaisrlikova, Jaroslav Čermák et al. · 2020 · Cells
51. Evidence That Regulation of Pri-miRNA/miRNA Expression Is Not a General Rule of miPEPs Function in Humans
    Anne Prel, Christine Dozier, Jean‐Philippe Combier, Serge Plaza, Arnaud Besson · 2021 · International Journal of Molecular Sciences
52. The anti-tumor effects of CT-26 derived exosomes enriched by MicroRNA-34a on murine model of colorectal cancer
    Maryam Sadat Hosseini, Kaveh Baghaei, Mahsa Hajivalili, Mohammad Reza Zali, Masoumeh Ebtekar, Davar Amani · 2021 · Life Sciences
53. Promising Biomarkers in Head and Neck Cancer: The Most Clinically Important miRNAs
    Arsinoe C. Thomaidou, Panagiota Batsaki, Maria Adamaki, Maria Goulielmaki, Constantin N. Baxevanis, Vassilis C. Zoumpourlis, Sotirios P. Fortis · 2022 · International Journal of Molecular Sciences
54. MicroRNAs in the pathogenesis of neuroblastoma
    Johannes Hubertus Schulte, Sebastian Horn, Stefanie Schlierf, Alexander R. Schramm, Lukas Carl Heukamp, Holger Christiansen, Reinhard Buettner, Bernd Berwanger, Angelika Eggert · 2008 · Cancer Letters
55. A p53-inducible microRNA-34a downregulates Ras signaling by targeting IMPDH
    Hwa-Ryeon Kim, Jae‐Seok Roe, Ji‐Eun Lee, In‐Young Hwang, Eun‐Jung Cho, Hong‐Duk Youn · 2012 · Biochemical and Biophysical Research Communications
56. Role of p53 suppression in the pathogenesis of hepatocellular carcinoma
    Heena Bholaram Choudhary, Satish K. Mandlik, Deepa S. Mandlik · 2023 · World Journal of Gastrointestinal Pathophysiology
57. MicroRNAs in cancer diagnosis and therapy: from bench to bedside
    Isamu Hoshino, Hisahiro Matsubara · 2012 · Surgery Today
58. Regulation of senescence by microRNA biogenesis factors
    Kotb Abdelmohsen, Subramanya Srikantan, Min Ju Kang, Myriam Gorospe · 2012 · Ageing Research Reviews
59. Inactivation of TP53 correlates with disease progression and low miR-34a expression in previously treated chronic lymphocytic leukemia patients
    Annika Maria Dufour, Giuseppe Palermo, Evelyn Zellmeier, Gudrun Mellert, Guillemette Duchâteau-Nguyen, Stephanie Schneider, Tobias Benthaus, Purvi M. Kakadia, Karsten Spiekermann, Wolfgang Hiddemann et al. · 2013 · Blood
60. Prospects of miRNA-Based Therapy for Pancreatic Cancer
    Priya Pai, Satyanarayana Rachagani, Chandrakanth Are, Surinder K. Batra · 2013 · Current Drug Targets
61. Transcriptional and translational regulation of cytokine signaling in inflammatory β-cell dysfunction and apoptosis
    Guy Wayne Novotny, Morten Lundh, Marie Balslev Backe, Dan Ploug Christensen, Jakob Bondo Hansen, Mattias Salling Dahllöf, Emil M.H. Pallesen, Thomas R Mandrup-Poulsen · 2012 · Archives of Biochemistry and Biophysics
62. Novel Mechanisms of Regulation of miRNAs in CLL
    Veronica Balatti, Mario Acunzo, Yuri Pekarky, Carlo Maria Croce · 2016 · Trends in cancer
63. Exploring the cell signalling in hepatocyte differentiation
    Rebecca Vasconcellos, Érika Costa de Alvarenga, Ricardo Cambraia Parreira, Swiany Silveira Lima, Rodrigo R. Resende · 2016 · Cellular Signalling
64. MiR-9 is overexpressed in spontaneous canine osteosarcoma and promotes a metastatic phenotype including invasion and migration in osteoblasts and osteosarcoma cell lines
    Joelle M. Fenger, Ryan David Roberts, Obiajulu Hans Iwenofu, Misty D. Bear, Xiaoli Zhang, Jason I. Couto, Jaime F. Modiano, William C. Kisseberth, Cheryl A. London · 2016 · BMC Cancer
65. Pien Tze Huang inhibits the proliferation of colorectal cancer cells by increasing the expression of miR-34c-5p
    Yun Wan, Aling Shen, Fei Qi, Jianfeng Chu, Qiaoyan Cai, Thomas J. Sferra, Jun Peng, Youqin Chen · 2017 · Experimental and Therapeutic Medicine
66. Analysis of the miR-34 family functions in breast cancer reveals annotation error of miR-34b
    Marie Elise Engkvist, Eva Wessel Stratford, Susanne Lorenz, Leonardo A. Meza‐Zepeda, Ola Myklebost, Else Munthe · 2017 · Scientific Reports
67. MicroRNA-34a Attenuates Metastasis and Chemoresistance of Bladder Cancer Cells by Targeting the TCF1/LEF1 Axis
    Xiaobing Liu, Xin Liu, Yuqi Wu, Zhenqiang Fang, Qingjian Wu, Chao Wu, Yaxing Hao, Xia Yang, Jiang Zhao, Jia Li et al. · 2018 · Cellular Physiology and Biochemistry
68. miR-34a induces immunosuppression in colorectal carcinoma through modulating a SIRT1/NF-κB/B7-H3/TNF-α axis
    Fanyi Meng, Man Gil Yang, Yinshuang Chen, Weichang Chen, Weipeng Wang · 2021 · Cancer Immunology Immunotherapy
69. Micro-RNA Expression and Function in Lymphomas
    Sukhinder K. Sandhu, Carlo Maria Croce, Ramiro Garzon · 2011 · Advances in Hematology
70. Emerging role of microRNAs in diagnosis and treatment of various diseases including ovarian cancer
    Parag P. Shah, Lauren Hutchinson, Sham S. Kakar · 2009 · Journal of Ovarian Research
71. MicroRNA-26a-mediated regulation of interleukin-2 expression in transformed avian lymphocyte lines
    Hongtao Xu, Yongxiu Yao, Lorraine P. Smith, Venugopal Nair · 2010 · Cancer Cell International
72. The Role of MicroRNAs in Kidney Disease
    Sydwell Mukhadi, Rodney Hull, Zukile Mbita, Zodwa Dlamini · 2015 · Non-Coding RNA
73. Canine Mammary Carcinomas: A Comparative Analysis of Altered Gene Expression
    Farruk M. Lutful Kabir, Carlos E. Alvarez, R. Bird · 2015 · Veterinary Sciences
74. Negative feedback regulation of AXL by miR-34a modulates apoptosis in lung cancer cells
    Chun-Yu Cho, Jhy-Shrian Huang, Shine‐Gwo Shiah, Shih-Ying Chung, Jong‐Ding Lay, Ya-Yu Yang, Gi‐Ming Lai, Ann‐Lii Cheng, Li‐Tzong Chen, Shuang‐En Chuang · 2015 · RNA
75. MicroRNAs as Oncogenes and Tumor Suppressors
    Eva E. Rufino‐Palomares, Fernando J. Reyes‐Zurita, José Antonio Lupiáñez, Pedro P. Medina · 2013 · Wiley eBooks
76. The emerging functions of the p53-miRNA network in stem cell biology
    Lin, Chao-Po, Choi, Yong Jin, Hicks, Geoffrey G., He, Lin · 2012 · Cell Cycle
77. Full-length hdmX transcripts decrease following genotoxic stress
    Markey, M, Berberich, S J · 2008 · Oncogene
78. p53 downregulates PD-L1 expression via miR-34a to inhibit the growth of triple-negative breast cancer cells: a potential clinical immunotherapeutic target
    Siyu Deng, Mengna Wang, Chenglong Wang, Yan Zeng, Xue Ying Qin, Yiwen Tan, Bing Liang, Youde Cao · 2022 · Molecular Biology Reports
79. microRNA Expression and Biogenesis in Cellular Response to Ionizing Radiation
    Aihong Mao, Yang Liu, Hong Zhang, Cuixia Di, Chao Sun · 2014 · DNA and Cell Biology
80. DNA Methylation of Tumor Suppressor Protein-Coding and Non-Coding Genes in Multiple Myeloma
    Kwan Yeung Wong, Chor Sang Chim · 2015 · Epigenomics
81. MicroRNA: Potential Targets for the Development of Novel Drugs?
    Wei Wu · 2010 · Drugs in R&D
82. Cortical Tubers: Windows into Dysregulation of Epilepsy Risk and Synaptic Signaling Genes by MicroRNAs
    Alan A. Dombkowski, Carlos Eduardo Alves Batista, Daniela Cukovic, Nicholas J. Carruthers, Ramya Ranganathan, Upasana Shukla, Paul M. Stemmer, Harry T. Chugani, Diane C. Chugani · 2014 · Cerebral Cortex
83. The role of microRNAs in hematopoietic stem cell and leukemic stem cell function
    Stephen S. Chung, Wenhuo Hu, Christopher Y. Park · 2011 · Therapeutic Advances in Hematology
84. Posttranscriptional regulation of gene expression—adding another layer of complexity to the DNA damage response
    Jorge Bouças, Arina Riabinska, Mladen Jokić, Grit Sophie Herter-Sprie, Shuhua Chen, Katja Höpker, Hans Christian Reinhardt · 2012 · Frontiers in Genetics
85. Therapeutic targeting of miRNAs in neuroblastoma
    Raymond L. Stallings, Niamh H. Foley, Kenneth R. Bryan, Patrick G. Buckley, Isabella M. Bray · 2010 · Expert Opinion on Therapeutic Targets
86. Down Regulation of miR-34a and miR-143 May Indirectly Inhibit p53 in Oral Squamous Cell Carcinoma: a Pilot Study
    Mayakannan Manikandan, Arunagiri Kuha Deva Magendhra Rao, Ganesan Arunkumar, Rajkumar Kottayasamy Seenivasagam, Ramamurthy Rajaraman, Arasambattu Kannan Munirajan · 2015 · Asian Pacific Journal of Cancer Prevention
87. miR‐34a/BCL‐2 signaling axis contributes to apoptosis in MPP+‐induced SH‐SY5Y cells
    Zahra Shanesazzade, Maryam Peymani, Kamran Ghaedi, Mohammad Hossein Nasr‐Esfahani · 2018 · Molecular Genetics & Genomic Medicine
88. Functions of MDMX in the Modulation of the p53‐Response
    Kristiaan Lenos, Aart G. Jochemsen · 2011 · BioMed Research International
89. miR-34a is a microRNA safeguard for Citrobacter-induced inflammatory colon oncogenesis
    Lihua Wang, Ergang Wang, Yi Wang, Robert C. Mines, Kun Xiang, Zhiguo Sun, Gaiting Zhou, Kai‐Yuan Chen, Nikolai Rakhilin, Shanshan Chao et al. · 2018 · eLife
90. MicroRNA Interference Technologies
    Zhiguo Wang · 2009 · Springer eBooks
91. MicroRNA-199a-3p and microRNA-34a regulate apoptosis in human osteosarcoma cells
    Ye Tian, Yingze Zhang, Wei Chen · 2014 · Bioscience Reports
92. Genome wide expression profiling of p53 regulated miRNAs in neuroblastoma
    Ali Rihani, Alan Van Goethem, Maté Ongenaert, Sara De Brouwer, Pieter‐Jan Volders, Saurabh Agarwal, Katleen De Preter, Pieter Mestdagh, Jason Matthew Shohet, Frank Speleman et al. · 2015 · Scientific Reports
93. Correlation between microRNA-34a levels and lens opacity severity in age-related cataracts
    Ke‐Hung Chien, S-J Chen, Liu H, H-M Chang, Lin‐Chung Woung, C-M Liang, JT Chen, T-J Lin, S-H Chiou, C-H Peng · 2013 · Eye
94. Unpredictable changes of selected miRNA in expression profile of HNSCC
    Katarzyna Monika Lamperska, Piotr Kozłowski, Tomasz Kolenda, Anna Teresiak, Renata Bliźniak, Weronika Przybyła, Michał M. Masternak, Paweł Golusiński, Wojciech Golusiński · 2016 · Cancer Biomarkers
95. Specific MAPK-Associated MicroRNAs in Serum Differentiate Pancreatic Cancer from Autoimmune Pancreatitis
    Manabu Akamatsu, Naohiko Makino, Yushi Ikeda, Akiko Matsuda, Miho Ito, Yasuharu Kakizaki, Yoshihiko Saito, Tetsuya Ishizawa, Toshikazu Kobayashi, Toru Furukawa et al. · 2016 · PLoS ONE
96. Interplay Between Transcription Factors and MicroRNAs Regulating Epithelial-Mesenchymal Transitions in Colorectal Cancer
    Markus Kaller, Heiko Hermeking · 2016 · Advances in experimental medicine and biology
97. MicroRNA‐34a: A Key Regulator in the Hallmarks of Renal Cell Carcinoma
    Eman Ali Toraih, Afaf Taha Ibrahiem, Manal Said Fawzy, Mohammad Hosny Hussein, Saeed Awad M. Alqahtani, Aly A. M. Shaalan · 2017 · Oxidative Medicine and Cellular Longevity
98. The role of microRNAs and nanoparticles in ovarian cancer: a review
    Leila Kafshdooz, Hojjat Pourfathi, Abolfazl Akbarzadeh, Taiebeh Kafshdooz, Zohre Razban, Roghayeh Sheervalilou, Naser Ebrahimi Sadr, Rovshan I. Khalilov, Siamak Saghfi, Taras S. Kavetskyy et al. · 2018 · Artificial Cells Nanomedicine and Biotechnology
99. p53 as a double-edged sword in the progression of non-alcoholic fatty liver disease
    Zhibin Yan, Xiaokang Miao, Bangzhi Zhang, Junqiu Xie · 2018 · Life Sciences
100. Curcumin-Alleviated Osteoarthritic Progression in Rats Fed a High-Fat Diet by Inhibiting Apoptosis and Activating Autophagy via Modulation of MicroRNA-34a
     Jiayu Yao, Xiaotong Liu, Yingxu Sun, Xin Dong, Li Liu, Hailun Gu · 2021 · Journal of Inflammation Research